Lixisenatide is a modified exendin-4 in which proline has been deleted from the C-terminal end and six lysines have been added (Fig
Therefore, the drug may overcome a challenge of diet and exercise, where the brain compensates for weight loss by lowering metabolic rate, making it difficult to maintain lower weight long-term
Small studies have suggested a parallel reduction in intrapancreatic fat content following initiation of GLP-1RA 52
From brand names like Mounjaro to Ozempic, these medications have been approved by the Food and Drug Administration to lower blood sugar levels
Garber AJ, Abrahamson MJ, Barzilay JI, et al
Wegovy augments our already existing GLP-1 that leads to decreased hunger, increased fullness and delayed stomach emptying of food, she explains